Abstract
Purpose
To investigate the effect of alteplase, either combined with stent-retriever thrombectomy or a direct aspiration first pass technique (ADAPT), in patients with large-vessel occlusion stroke.
Methods
This was a retrospective post hoc analysis of data from The Direct Mechanical Thrombectomy in Acute LVO Stroke (SKIP) study. Patients were divided into two groups according to the first-line thrombectomy technique: stent-retriever and ADAPT. Each group was further divided into two subgroups, namely MT and MT + alteplase. The procedural outcomes, such as first pass effect (FPE) ratio and number of passes, were evaluated. The clinical outcomes included mRS score at 3 months.
Results
A total of 180 patients were included (116 in the stent-retriever group and 64 in the ADAPT group). No interaction was detected between the first-line technique and alteplase administration. In the stent-retriever group, after adjusting for factors associated with FPE, the adjusted odds ratio (95% confidence interval) of FPE of the MT + alteplase subgroup versus the MT subgroup was 3.57 (1.5–8.48) and in the ADAPT group it was 1.35 (0.37–4.91). With alteplase, the number of passes decreased with adjusted odds ratios of 0.59 (0.37–0.93) in the stent-retriever group but not in the ADAPT group. In both first-line technique groups, clinical outcomes did not differ between subgroups.
Conclusion
In the SKIP study, alteplase administration was associated with increased FPE when combined with stent-retriever thrombectomy, but not with ADAPT. We found no differences in the clinical outcomes.
Similar content being viewed by others
References
Lapergue B, Blanc R, Gory B, Labreuche J, Duhamel A, Marnat G, Saleme S, Costalat V, Bracard S, Desal H, Mazighi M, Consoli A, Piotin M; ASTER Trial Investigators. Effect of Endovascular Contact Aspiration vs Stent Retriever on Revascularization in Patients With Acute Ischemic Stroke and Large Vessel Occlusion: The ASTER Randomized Clinical Trial. JAMA. 2017;318:443–52.
Turk AS 3rd, Siddiqui A, Fifi JT, De Leacy RA, Fiorella DJ, Gu E, Levy EI, Snyder KV, Hanel RA, Aghaebrahim A, Woodward BK, Hixson HR, Chaudry MI, Spiotta AM, Rai AT, Frei D, Almandoz JED, Kelly M, Arthur A, Baxter B, English J, Linfante I, Fargen KM, Mocco J. Aspiration thrombectomy versus stent retriever thrombectomy as first-line approach for large vessel occlusion (COMPASS): a multicentre, randomised, open label, blinded outcome, non-inferiority trial. Lancet. 2019;393:998–1008.
Ducroux C, Piotin M, Gory B, Labreuche J, Blanc R, Ben Maacha M, Lapergue B, Fahed R; ASTER Trial investigators. First pass effect with contact aspiration and stent retrievers in the Aspiration versus Stent Retriever (ASTER) trial. J Neurointerv Surg. 2020;12:386–91.
Qin C, Shang K, Xu SB, Wang W, Zhang Q, Tian DS. Efficacy and safety of direct aspiration versus stent-retriever for recanalization in acute cerebral infarction: A PRISMA-compliant systematic review and meta-analysis. Medicine (Baltimore). 2018;97:e12770.
Turk AS, Spiotta A, Frei D, Mocco J, Baxter B, Fiorella D, Siddiqui A, Mokin M, Dewan M, Woo H, Turner R, Hawk H, Miranpuri A, Chaudry I. Initial clinical experience with the ADAPT technique: a direct aspiration first pass technique for stroke thrombectomy. J Neurointerv Surg. 2014;6:231–7.
Chandra RV, Leslie-Mazwi TM, Mehta BP, Derdeyn CP, Demchuk AM, Menon BK, Goyal M, González RG, Hirsch JA. Does the use of IV tPA in the current era of rapid and predictable recanalization by mechanical embolectomy represent good value? J Neurointerv Surg. 2016;8:443–6.
Zaidat OO, Castonguay AC, Linfante I, Gupta R, Martin CO, Holloway WE, Mueller-Kronast N, English JD, Dabus G, Malisch TW, Marden FA, Bozorgchami H, Xavier A, Rai AT, Froehler MT, Badruddin A, Nguyen TN, Taqi MA, Abraham MG, Yoo AJ, Janardhan V, Shaltoni H, Novakovic R, Abou-Chebl A, Chen PR, Britz GW, Sun CJ, Bansal V, Kaushal R, Nanda A, Nogueira RG. First Pass Effect: A New Measure for Stroke Thrombectomy Devices. Stroke. 2018;49:660–6.
Nikoubashman O, Dekeyzer S, Riabikin A, Keulers A, Reich A, Mpotsaris A, Wiesmann M. True First-Pass Effect. Stroke. 2019;50:2140–6.
Mokin M, Primiani CT, Castonguay AC, Nogueira RG, Haussen DC, English JD, Satti SR, Chen J, Farid H, Borders C, Veznedaroglu E, Binning MJ, Puri A, Vora NA, Budzik RF, Dabus G, Linfante I, Janardhan V, Alshekhlee A, Abraham MG, Edgell R, Taqi MA, Khoury RE, Majjhoo AQ, Kabbani MR, Froehler MT, Finch I, Ansari SA, Novakovic R, Nguyen TN, Zaidat OO. First Pass Effect in Patients Treated With the Trevo Stent-Retriever: A TRACK Registry Study Analysis. Front Neurol. 2020;11:83.
Hao Y, Yang D, Wang H, Zi W, Zhang M, Geng Y, Zhou Z, Wang W, Xu H, Tian X, Lv P, Liu Y, Xiong Y, Liu X, Xu G; ACTUAL Investigators (Endovascular Treatment for Acute Anterior Circulation Ischemic Stroke Registry). Predictors for Symptomatic Intracranial Hemorrhage After Endovascular Treatment of Acute Ischemic Stroke. Stroke. 2017;48:1203–9.
Renú A, Laredo C, Lopez-Rueda A, Llull L, Tudela R, San-Roman L, Urra X, Blasco J, Macho J, Oleaga L, Chamorro A, Amaro S. Vessel Wall Enhancement and Blood-Cerebrospinal Fluid Barrier Disruption After Mechanical Thrombectomy in Acute Ischemic Stroke. Stroke. 2017;48:651–7.
Sasaki R, Yamashita T, Tadokoro K, Matsumoto N, Nomura E, Omote Y, Takemoto M, Hishikawa N, Ohta Y, Abe K. Direct arterial damage and neurovascular unit disruption by mechanical thrombectomy in a rat stroke model. J Neurosci Res. 2020;98:2018–26.
Maros ME, Brekenfeld C, Broocks G, Leischner H, McDonough R, Deb-Chatterji M, Alegiani A, Thomalla G, Fiehler J, Flottmann F; GSR Investigators*. Number of Retrieval Attempts Rather Than Procedure Time Is Associated With Risk of Symptomatic Intracranial Hemorrhage. Stroke. 2021;52:1580–8.
Teng D, Pannell JS, Rennert RC, Li J, Li YS, Wong VW, Chien S, Khalessi AA. Endothelial trauma from mechanical thrombectomy in acute stroke: in vitro live-cell platform with animal validation. Stroke. 2015;46:1099–106.
Suzuki K, Kimura K, Takeuchi M, Morimoto M, Kanazawa R, Kamiya Y, Shigeta K, Ishii N, Takayama Y, Koguchi Y, Takigawa T, Hayakawa M, Ota T, Okubo S, Naito H, Akaji K, Kato N, Inoue M, Hirano T, Miki K, Ueda T, Iguchi Y, Fujimoto S, Otsuka T, Matsumaru Y. The randomized study of endovascular therapy with versus without intravenous tissue plasminogen activator in acute stroke with ICA and M1 occlusion (SKIP study). Int J Stroke. 2019;14:752–5.
Suzuki K, Matsumaru Y, Takeuchi M, Morimoto M, Kanazawa R, Takayama Y, Kamiya Y, Shigeta K, Okubo S, Hayakawa M, Ishii N, Koguchi Y, Takigawa T, Inoue M, Naito H, Ota T, Hirano T, Kato N, Ueda T, Iguchi Y, Akaji K, Tsuruta W, Miki K, Fujimoto S, Higashida T, Iwasaki M, Aoki J, Nishiyama Y, Otsuka T, Kimura K; SKIP Study Investigators. Effect of Mechanical Thrombectomy Without vs With Intravenous Thrombolysis on Functional Outcome Among Patients With Acute Ischemic Stroke: The SKIP Randomized Clinical Trial. JAMA. 2021;325:244–253. Erratum in: JAMA. 2021;325:1795.
Yamaguchi T, Mori E, Minematsu K, Nakagawara J, Hashi K, Saito I, Shinohara Y; Japan Alteplase Clinical Trial (J-ACT) Group. Alteplase at 0.6 mg/kg for acute ischemic stroke within 3 hours of onset: Japan Alteplase Clinical Trial (J-ACT). Stroke. 2006;37:1810–5.
Goyal M, Fargen KM, Turk AS, Mocco J, Liebeskind DS, Frei D, Demchuk AM. 2C or not 2C: defining an improved revascularization grading scale and the need for standardization of angiography outcomes in stroke trials. J Neurointerv Surg. 2014;6:83–6.
National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med. 1995;333:1581–7.
Wahlgren N, Ahmed N, Dávalos A, Ford GA, Grond M, Hacke W, Hennerici MG, Kaste M, Kuelkens S, Larrue V, Lees KR, Roine RO, Soinne L, Toni D, Vanhooren G; SITS-MOST investigators. Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study. Lancet. 2007;369:275–82. Erratum in: Lancet. 2007;369:826.
Di Maria F, Kyheng M, Consoli A, Desilles JP, Gory B, Richard S, Rodesch G, Labreuche J, Girot JB, Dargazanli C, Marnat G, Lapergue B, Bourcier R; ETIS investigators*. Identifying the predictors of first-pass effect and its influence on clinical outcome in the setting of endovascular thrombectomy for acute ischemic stroke: Results from a multicentric prospective registry. Int J Stroke. 2021;16:20–28.
Srivatsa S, Duan Y, Sheppard JP, Pahwa S, Pace J, Zhou X, Bambakidis NC. Cerebral vessel anatomy as a predictor of first-pass effect in mechanical thrombectomy for emergent large-vessel occlusion. J Neurosurg. 2020; doi: 10.3171/2019.11.JNS192673. Epub ahead of print.
Marnat G, Barreau X, Detraz L, Bourcier R, Gory B, Sgreccia A, Gariel F, Berge J, Menegon P, Kyheng M, Labreuche J, Consoli A, Blanc R, Lapergue B; ETIS Investigators. First-Line Sofia Aspiration Thrombectomy Approach within the Endovascular Treatment of Ischemic Stroke Multicentric Registry: Efficacy, Safety, and Predictive Factors of Success. AJNR Am J Neuroradiol. 2019;40:1006–12.
Kanda Y. Investigation of the freely available easy-to-use software ‘EZR’ for medical statistics. Bone Marrow Transplant. 2013;48:452–8.
Machi P, Costalat V, Lobotesis K, Lima Maldonado I, Vendrell JF, Riquelme C, Bonafé A. Solitaire FR thrombectomy system: immediate results in 56 consecutive acute ischemic stroke patients. J Neurointerv Surg. 2018;10(Suppl 1):i27–32.
Alexandrov AV, Molina CA, Grotta JC, Garami Z, Ford SR, Alvarez-Sabin J, Montaner J, Saqqur M, Demchuk AM, Moyé LA, Hill MD, Wojner AW; CLOTBUST Investigators. Ultrasound-enhanced systemic thrombolysis for acute ischemic stroke. N Engl J Med. 2004;351:2170–8.
Chalos V, LeCouffe NE, Uyttenboogaart M, Lingsma HF, Mulder MJHL, Venema E, Treurniet KM, Eshghi O, van der Worp HB, van der Lugt A, Roos YBWEM, Majoie CBLM, Dippel DWJ, Roozenbeek B, Coutinho JM; MR CLEAN Registry Investigators. Endovascular Treatment With or Without Prior Intravenous Alteplase for Acute Ischemic Stroke. J Am Heart Assoc. 2019;8:e011592.
Zaidat OO, Haussen DC, Hassan AE, Jadhav AP, Mehta BP, Mokin M, Mueller-Kronast NH, Froehler MT. Impact of Stent Retriever Size on Clinical and Angiographic Outcomes in the STRATIS Stroke Thrombectomy Registry. Stroke. 2019;50:441–7.
Zaidat OO, Bozorgchami H, Ribó M, Saver JL, Mattle HP, Chapot R, Narata AP, Francois O, Jadhav AP, Grossberg JA, Riedel CH, Tomasello A, Clark WM, Nordmeyer H, Lin E, Nogueira RG, Yoo AJ, Jovin TG, Siddiqui AH, Bernard T, Claffey M, Andersson T. Primary Results of the Multicenter ARISE II Study (Analysis of Revascularization in Ischemic Stroke With EmboTrap). Stroke. 2018;49:1107–15.
Tomasello A, Ribò M, Gramegna LL, Melendez F, Rosati S, Moreu M, Aixut S, Lüttich A, Werner M, Remollo S, Quintana M, Coscojuela P, Hernandez D, Dinia L, Lopez-Rueda A, Rubiera M, Rovira À. Procedural approaches and angiographic signs predicting first-pass recanalization in patients treated with mechanical thrombectomy for acute ischaemic stroke. Interv Neuroradiol. 2019;25:491–6.
Delgado Almandoz JE, Kayan Y, Wallace AN, Tarrel RM, Fease JL, Scholz JM, Milner AM, Roohani P, Mulder M, Young ML. Larger ACE 68 aspiration catheter increases first-pass efficacy of ADAPT technique. J Neurointerv Surg. 2019;11:141–6.
Abilleira S, Ribera A, Cardona P, Rubiera M, López-Cancio E, Amaro S, Rodríguez-Campello A, Camps-Renom P, Cánovas D, de Miquel MA, Tomasello A, Remollo S, López-Rueda A, Vivas E, Perendreu J, Gallofré M; Catalan Stroke Code and Reperfusion Consortium. Outcomes After Direct Thrombectomy or Combined Intravenous and Endovascular Treatment Are Not Different. Stroke. 2017;48:375–8.
Alonso de Leciñana M, Martínez-Sánchez P, García-Pastor A, Kawiorski MM, Calleja P, Sanz-Cuesta BE, Díaz-Otero F, Frutos R, Sierra-Hidalgo F, Ruiz-Ares G, Fandiño E, Díez-Tejedor E, Gil-Nuñez A, Fuentes B. Mechanical thrombectomy in patients with medical contraindications for intravenous thrombolysis: a prospective observational study. J Neurointerv Surg. 2017;9:1041–6.
Merlino G, Sponza M, Petralia B, Vit A, Gavrilovic V, Pellegrin A, Rana M, Cancelli I, Naliato S, Lorenzut S, Marinig R, Calzolari F, Eleopra R. Short and long-term outcomes after combined intravenous thrombolysis and mechanical thrombectomy versus direct mechanical thrombectomy: a prospective single-center study. J Thromb Thrombolysis. 2017;44:203–9.
Funding
This study was supported by Japanese Society for Neuroendovascular Therapy (JSNET). The funding sources had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.
Author information
Authors and Affiliations
Consortia
Contributions
Prof. Kazumi Kimura and Dr. Kentaro Suzuki had full access to all the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis. The first (K. Shigeta) and last (KK) authors drafted the manuscript, and all authors contributed substantially to its revision. K. Shigeta analyzed the data. KK and K. Suzuki obtained research funding. K. Shigeta, K. Suzuki, YM, MT, MM, RK, YT, Y. Kamiya, SO, MH, NI, Y. Koguchi, TO, TT, MI, HN, NK, TU, KA, YI, KM, WT, ME, JA, TN, KK undertook recruitment of participating centers and patients and managed the data, including quality control. TH and SF served as an independent imaging committee. K. Shigeta takes responsibility for the paper as a whole.
Corresponding author
Ethics declarations
Conflict of interest
K. Shigeta, K. Suzuki, M. Morimoto, R. Kanazawa, Y. Takayama, S. Okubo, M. Hayakawa, N. Ishii, Y. Koguchi, T. Ota, T. Takigawa, M. Inoue, H. Naito, N. Kato, T. Ueda, K. Akaji, K. Miki, W. Tsuruta, S. Fujimoto, M. Enomoto, J. Aoyama and T. Nakano declare that they have no competing interests. K. Kimura received lecture fees from Bristol Myers Squibb, Nippon Boehringer Ingelheim, Bayer Healthcare, and Daiichi Sankyo; research funding from Nippon Boehringer Ingelheim, Daiichi Sankyo, Pfizer Japan, Medtronic, and Teijin Pharma; and personal funding from the 38th Mihara Cerebrovascular Disorder Research Promotion Fund. M. Takeuchi received lecture fees from Stryker. Shigeru Fujimoto received lecture fees from Nippon Boehringer Ingelheim, Daiichi Sankyo, Pfizer Japan, Bristol Myers Squibb Co. Ltd., Bayer Healthcare, and Takeda Pharmaceutical. T. Hirano received lecture fees from Bayer Healthcare, Daiichi Sankyo, Nippon Boehringer Ingelheim, Bristol Myers Squibb, Medtronic, Sanofi, Otsuka Pharmaceutical, Mitsubishi Tanabe Pharma, CSL Behring, Astellas Pharma, and Pfizer Japan. Y. Iguchi received lecture fees from Bayer Healthcare, Pfizer Japan, Nippon Boehringer Ingelheim, Takeda Pharmaceutical, Otsuka Pharmaceutical, and Daiichi Sankyo; and research funding from Sanofi. Y. Kamiya received lecture fees from Daiichi Sankyo; and research funding from Bristol Myers Squibb. Y. Matsumaru received lecture fees from Medtronic, Stryker, Sanofi, Daiichi Sankyo, Otsuka Pharmaceutical, and Biomedical solutions.
Ethical standards
The SKIP study was approved by the local institutional review boards, and written informed consent was obtained from all study participants. Because this study used existing anonymized information from the SKIP study, written informed consent from the study subjects was exempted in accordance with the Ethical Guidelines for Medical and Health Research Involving Human Subject in Japan. Consent to publish: not applicable.
Additional information
Trial Registration: https://upload.umin.ac.jp/cgi-open-bin/ctr/ctr_view.cgi?recptno=R000024783:UMIN000021488
Availability of Data and Material
The data of this study are available from the corresponding author upon reasonable request.
Supplementary Information
62_2021_1085_MOESM1_ESM.docx
Online Resource 1. Patient baseline and clinical characteristics. Online Resource 2. Matched pair analysis of primary outcomes by subgroup
Rights and permissions
About this article
Cite this article
Shigeta, K., Suzuki, K., Matsumaru, Y. et al. Intravenous Alteplase is Associated with First Pass Effect in Stent-retriever but not ADAPT Thrombectomy. Clin Neuroradiol 32, 153–162 (2022). https://doi.org/10.1007/s00062-021-01085-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00062-021-01085-3